CD44 and cancer: Recently, in colorectal carcinoma, Ganesh et al37 have established a link between L1CAM and cancer stemness, where L1CAM characterizes a CD133/CD44 expressing stem‐like cells population endowed with enhanced tumorigenic potential and increased chemoresistance.